norfloxacin has been researched along with chloramphenicol in 116 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (6.03) | 18.7374 |
| 1990's | 14 (12.07) | 18.2507 |
| 2000's | 31 (26.72) | 29.6817 |
| 2010's | 59 (50.86) | 24.3611 |
| 2020's | 5 (4.31) | 2.80 |
| Authors | Studies |
|---|---|
| Apiwattanakul, N; Endou, H; Jariyawat, S; Kanai, Y; Sekine, T; Sophasan, S; Takeda, M | 1 |
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Drlica, K; Hussain, S; Malik, M | 1 |
| Arpin, C; Ba, BB; Caignard, DH; Forfar-Bares, I; Grellet, J; Guillon, J; Jarry, C; Moreau, S; Quentin, C; Vidaillac, C | 1 |
| Levy, SB; Nicoloff, H; Perreten, V | 1 |
| Akamatsu, M; Fujikawa, M; Nakao, K; Shimizu, R | 1 |
| Courvalin, P; Galimand, M; Périchon, B | 1 |
| Al-Momani, W; Antunes, NT; Assunção, P; Ayling, RD; Mercier, P; Poveda, JB; Rosales, RS; Tavío, MM | 1 |
| Beceiro, A; Bou, G; Canle, D; Fernández, A; Lasa, I; Latasa, C; Mallo, S; Molina, F; Pérez, A; Pérez, S; Poza, M; Tomás, Mdel M; Villanueva, R | 1 |
| Ackerley, DF; Andersen, GL; Benoit, MR; Brodie, EL; Dixon, L; Hu, P; Keyhan, M; Lynch, SV; Matin, A | 1 |
| Chen, T; Khalil, H; Riffon, R; Wang, R; Wang, Z | 1 |
| Bammert, GF; Banitt, LS; Barbachyn, MR; Boyle, TP; Bundy, GL; Dolak, LA; Ford, CW; Graber, DR; Hamel, JC; Han, F; Harris, DW; Hromockyj, AE; Hurd, AR; Kamilar, GM; Marotti, KR; Martin, GE; Miller, AA; Mott, JE; Munzner, JB; Palmer, JR; Ruble, JC; Seest, EP; Skepner, JE; Sweeney, MT; Zhong, WZ; Zurenko, GE | 1 |
| Long, F; Rouquette-Loughlin, C; Shafer, WM; Yu, EW | 1 |
| Cattoir, V; Nordmann, P; Poirel, L | 1 |
| Bailey, AM; Paulsen, IT; Piddock, LJ | 1 |
| Chevalier, J; Davin-Regli, A; Dupont, M; Lavigne, JP; Pagès, JM; Sotto, A; Tran, QT | 1 |
| Wang, X; Zhao, X | 1 |
| Hiramatsu, K; Kikuchi, K; Ohtsuka, M; Ono, Y; Sasaki, T; Shimizu, K; Takahashi, N | 1 |
| Hamamoto, H; Kurokawa, K; Lee, BL; Maki, H; Matsuo, M; Murakami, K; Nishida, S; Sekimizu, K; Yamane, N | 1 |
| Espinal, P; Gibert, I; Marti, S; Martínez, P; Roca, I; Vila, J | 1 |
| Gaillard, JL; Jackson, M; McDonnell, G; Niederweis, M; Skovierová, H; Svetlíková, Z | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Brasme, L; De Champs, C; Duval, V; Forte, D; Guillard, T; Madoux, J; Maiga, A; Maiga, I; Vernet-Garnier, V | 1 |
| Hashida, Y; Konaka, R; Kourai, H; Maseda, H; Shirai, A | 1 |
| Gebreyes, WA; Rajamohan, G; Srinivasan, VB | 1 |
| Courvalin, P; Coyne, S; Guigon, G; Périchon, B | 1 |
| Fàbrega, A; Martin, RG; Rosner, JL; Tavio, MM; Vila, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Hakanen, AJ; Huovinen, P; Kotilainen, P; Lehtopolku, M; Nakari, UM; Siitonen, A | 1 |
| Alibert-Franco, S; Bolla, JM; Kuete, V; Ngadjui, BT; Ngameni, B; Pagès, JM; Tangmouo, JG | 1 |
| Gan, LL; Zhang, FF; Zhou, CH | 1 |
| Levy, SB; Ruiz, C | 1 |
| Avdeef, A; Tam, KY | 1 |
| Mima, T; Schweizer, HP | 1 |
| Fang, B; Rao, XC; Zhou, CH | 1 |
| Bohnert, JA; Karamian, B; Nikaido, H | 1 |
| Chen, S; Chen, Z; Deng, Y; Huang, X; Liu, JH; Liu, Y; Sun, Y; Tian, W; Wu, C; Zeng, Z; Zhao, J | 1 |
| Gadakh, AV; Karale, BK; Pandit, C; Rindhe, SS | 1 |
| Gotoh, N; Hayashi, N; Okuda, J; Wakahara, Y | 1 |
| Mali, MD; Patel, MM; Patel, SK | 1 |
| Akamatsu, M | 1 |
| Makawana, JA; Mungra, DC; Patel, MP; Patel, RG | 1 |
| Akhaja, TN; Raval, JP | 1 |
| Anderson, KC; Kellogg, GE; Sarkar, A | 1 |
| Barad, HA; Gupta, VK; Kant, R; Pansuriya, BR; Parmar, NJ; Teraiya, SB | 1 |
| Barad, HA; Gupta, VK; Kant, R; Pansuriya, BR; Parmar, NJ | 1 |
| Patel, MP; Patel, RG; Shah, NM | 1 |
| Bonifácio, VD; Gawande, MB; Mhaske, GR; Shelke, SN | 1 |
| Damu, GL; Geng, RX; Zhang, L; Zhang, SL; Zhou, CH | 1 |
| Chang, JJ; Damu, GL; Fang, B; Geng, RX; Zhang, SL; Zhou, CH; Zhou, XD | 1 |
| Parmar, BD; Parmar, NJ; Patel, RA; Talpada, NP | 1 |
| Kathrotiya, HG; Patel, MP | 1 |
| Cui, SF; Damu, GL; Geng, RX; Peng, XM; Ren, Y; Zhang, SL; Zhou, CH | 1 |
| Kanawade, SB; Rajani, DP; Toche, RB | 1 |
| Cai, GX; Damu, GL; Zhang, HZ; Zhou, CH | 1 |
| Jardosh, HH; Patel, MP | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Geng, RX; Peng, XM; Rasheed, S; Yan, CY; Yin, BT; Zhang, SL; Zhou, CH | 1 |
| Kishore, B; Lv, JS; Peng, XM; Zhou, CH | 1 |
| Kalaria, PN; Raval, DK; Satasia, SP | 1 |
| Karad, SC; Purohit, VB; Raval, DK | 1 |
| Karad, SC; Purohit, VB; Raval, DK; Thakkar, VR; Thakor, P | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Addla, D; Cui, SF; Zhou, CH | 1 |
| Avula, SR; Jeyakkumar, P; Zhang, L; Zhou, CH | 1 |
| Addla, D; Avula, SR; Cheng, Y; Gao, WW; Lin, JM; Tangadanchu, VKR; Zhang, L; Zhou, CH | 1 |
| Kamani, RD; Karad, SC; Purohit, VB; Raval, DK; Ray, A; Thakkar, SS; Thakkar, VR; Thakor, P; Thummar, RP; Vaghasiya, BK | 1 |
| Cheng, Y; Geng, RX; Gopala, L; Jeyakkumar, P; Liu, HB; Peng, XM; Zhou, CH | 1 |
| Gan, LL; Gopala, L; He, SC; Peng, YJ; Tangadanchu, VKR; Zhang, HJ; Zhang, HZ; Zhou, CH | 1 |
| Doshi, H; Ray, A; Thakkar, SS; Thakor, P | 1 |
| Doshi, H; Ray, A; Thakkar, SS; Thakkar, VR; Thakor, P | 1 |
| Bheemanaboina, RRY; Kannekanti, VK; Li, ZZ; Maddili, SK; Tangadanchu, VKR; Tuniki, B; Zhou, CH | 1 |
| Bai, L; Deng, J; Feng, L; Lv, Z; Wang, Y; Xu, Z; Zhang, F; Zhao, S | 1 |
| Bukharov, SV; Burilov, AR; Gibadullina, EM; Pazilova, NB; Pudovik, MA; Sapunova, AS; Starodubtseva, RR; Sudakov, IA; Voloshina, AD; Vyshtakalyuk, AB | 1 |
| Zhang, B | 1 |
| Ba, Y; Hou, X; Wang, S; Xu, Z; Yang, H; Zhang, J | 1 |
| Gao, F; Huang, G; Xiao, J | 1 |
| Beteck, RM; Jesumoroti, OJ; Legoabe, LJ; Patel, OPS | 1 |
| Daraji, DG; Jayanthi, S; Patel, HD; Pithawala, EA; Rajani, DP; Rajani, SD | 1 |
| Hannan, A | 1 |
| Hancock, RE; Young, M | 1 |
| Cook, T; Miller, IM; Vogel, R; Wittreich, JM | 1 |
| Fukuda, H; Hashimoto, H; Hirai, K; Iyobe, S; Jakics, EB | 1 |
| Agarwal, S; Guleria, JS; Madhu, SV; Talwar, V | 1 |
| Avisar, R; Hundart, O; Lerner, N; Savir, H; Vender, T; Yasur, Y | 1 |
| Cohen, SP; Hooper, DC; Levy, SB; McMurry, LM; Wolfson, JS | 1 |
| Zeiler, HJ | 1 |
| Martin, E; Nauciel, C | 1 |
| Hackbarth, CJ; Sande, MA; Shibl, AM | 1 |
| Bonanni, M; Iegri, F; Lorenzi, A; Mascellino, MT | 1 |
| Drusano, GL; Morris, JG; Tenney, JH | 1 |
| Li, XZ; Livermore, DM; Nikaido, H | 1 |
| Mortimer, PG; Piddock, LJ | 1 |
| Li, XZ; Nikaido, H; Poole, K | 1 |
| Gotoh, N; Li, XZ; Neshat, S; Nishino, T; Poole, K; Tsujimoto, H; Wada, A; Yamagishi, J; Yamasaki, T; Zhao, Q | 1 |
| Ishiguro, EE; Rodionov, DG | 1 |
| Courvalin, P; Lynch, C; Nikaido, H | 1 |
| Deguchi, K; Ishihara, R; Ishii, Y; Nakazawa, A; Suzuki, Y | 1 |
| Araj, GF; Zouain, MG | 1 |
| Bal, AM; Ghadage, DP | 1 |
| Chan, CM; Li, L; Tan, DT; Theng, JT | 1 |
| Tabata, M; Takata, T; Tsuruoka, T; Watabe, H | 1 |
| Biswas, A; Kumar, AA; Ramakrishnan, MA; Shivachandra, SB; Singh, VP; Srivastava, SK | 1 |
| Bassily, S; El Masry, NA; Haberberger, RL; Mikhail, I; Woody, JN; Yassa, M; Zakaria, S | 1 |
| Gerkowicz, M; Gruszecka-Gerkowicz, R; Kosior-Jarecka, E; Pietraś-Trzpiel, M | 1 |
| Li, XD; Liu, YC; Xu, WH; Zhang, G; Zou, SC | 1 |
| Adam, E; Baitiche, M; Chevalier, J; Mahamoud, A; Pagès, JM | 1 |
| Chen, CP; Chen, TL; Fan, NW; Lee, SM; Lin, PY | 1 |
| Chu, LM; Pan, M | 1 |
| Ahn, J; Ding, T; Jo, A; Kim, J; Lee, HY | 1 |
| Akutagawa, M; Emoto, T; Harada, Y; Hou, Y; Kinouchi, Y; Mawatari, K; Nakahashi, M; Shimohata, T; Takahashi, A; Tsunedomi, A; Uebanso, T | 1 |
| Abdenaceur, H; Beltifa, A; Ben Mansour, H; Ghorbel, A; Mehri, I; Reyns, T; Sire, O; Van Loco, J; Zouiten, A | 1 |
| Al-Ajmi, D; Banu, S; Rahman, S | 1 |
| Abebe, N; Ahmed, M; Awol, N; Bsrat, A; Gugsa, G; Hagos, Y; Tsegaye, Y | 1 |
| Fang, C; Huang, Q; Liu, C; Shao, C; Wang, H; Wang, S; Xu, H | 1 |
6 review(s) available for norfloxacin and chloramphenicol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Benzofuran derivatives and their anti-tubercular, anti-bacterial activities.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Benzofurans; Humans; Structure-Activity Relationship | 2019 |
Comprehensive review on the anti-bacterial activity of 1,2,3-triazole hybrids.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazoles | 2019 |
Nitroimidazole-containing compounds and their antibacterial and antitubercular activities.
Topics: Anti-Bacterial Agents; Bacterial Infections; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure; Nitroimidazoles | 2019 |
Current scenario of tetrazole hybrids for antibacterial activity.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Tetrazoles | 2019 |
Metronidazole-conjugates: A comprehensive review of recent developments towards synthesis and medicinal perspective.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Antiprotozoal Agents; Drug Development; Humans; Hypoglycemic Agents; Metronidazole | 2021 |
2 trial(s) available for norfloxacin and chloramphenicol
| Article | Year |
|---|---|
The safety and efficacy of topical norfloxacin compared with chloramphenicol for the treatment of external ocular bacterial infections. The Norfloxacin-Chloramphenicol Ophthalmic Study Group.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Blepharitis; Child; Child, Preschool; Chloramphenicol; Conjunctivitis, Bacterial; Double-Blind Method; Female; Humans; Male; Middle Aged; Norfloxacin | 1992 |
[Changes in bacterial flora of conjunctival sac in patients prophylacticaly treated with antibiotic before cataract operation].
Topics: Antibiotic Prophylaxis; Cataract; Cataract Extraction; Chloramphenicol; Conjunctiva; Conjunctivitis, Bacterial; Female; Gentamicins; Humans; Male; Norfloxacin; Ofloxacin | 2005 |
108 other study(ies) available for norfloxacin and chloramphenicol
| Article | Year |
|---|---|
The interaction and transport of beta-lactam antibiotics with the cloned rat renal organic anion transporter 1.
Topics: Animals; Anion Transport Proteins; Anti-Bacterial Agents; Biological Transport; Carrier Proteins; Cell Survival; Cephaloridine; Cephalosporins; In Vitro Techniques; Kidney; Kinetics; Oocytes; p-Aminohippuric Acid; Penicillin G; Rats; Recombinant Proteins; Xenopus laevis | 1999 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Effect of anaerobic growth on quinolone lethality with Escherichia coli.
Topics: Aerobiosis; Anaerobiosis; Anti-Infective Agents; Chloramphenicol; Ciprofloxacin; DNA Fragmentation; DNA Gyrase; DNA, Bacterial; DnaB Helicases; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Escherichia coli; Microbial Sensitivity Tests; Models, Biological; Molecular Structure; Nalidixic Acid; Quinolones | 2007 |
Synthesis of omeprazole analogues and evaluation of these as potential inhibitors of the multidrug efflux pump NorA of Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Culture Media; Drug Resistance, Multiple, Bacterial; Enzyme Inhibitors; Indicators and Reagents; Kinetics; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Norfloxacin; Omeprazole; Staphylococcus aureus; Structure-Activity Relationship | 2007 |
Increased genome instability in Escherichia coli lon mutants: relation to emergence of multiple-antibiotic-resistant (Mar) mutants caused by insertion sequence elements and large tandem genomic amplifications.
Topics: Anti-Bacterial Agents; DNA Transposable Elements; DNA-Binding Proteins; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Gene Amplification; Genome, Bacterial; Genomic Instability; Multidrug Resistance-Associated Proteins; Mutation; Protease La | 2007 |
QSAR study on permeability of hydrophobic compounds with artificial membranes.
Topics: Biological Transport; Caco-2 Cells; Drug Evaluation, Preclinical; Humans; Hydrophobic and Hydrophilic Interactions; Membranes, Artificial; Permeability; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship | 2007 |
Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli.
Topics: Amino Acid Motifs; Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Conjugation, Genetic; Conserved Sequence; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Genes, rRNA; Methylation; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Norfloxacin; Plasmids; Sequence Analysis, DNA; Sequence Homology, Amino Acid | 2007 |
In vitro susceptibilities of Mycoplasma putrefaciens field isolates.
Topics: Anti-Bacterial Agents; France; Humans; Jordan; Lincomycin; Macrolides; Microbial Sensitivity Tests; Mycoplasma; Mycoplasma Infections; Tetracycline Resistance | 2007 |
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
Topics: Bacterial Proteins; Base Sequence; beta-Lactamases; Carrier Proteins; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, MDR; Genetic Vectors; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Porins | 2007 |
Role of the rapA gene in controlling antibiotic resistance of Escherichia coli biofilms.
Topics: Anti-Bacterial Agents; beta-Lactamases; Biofilms; Blotting, Western; DNA Primers; Drug Resistance, Bacterial; Escherichia coli K12; Gene Deletion; Genes, Bacterial; Genetic Complementation Test; Genetic Vectors; Penicillin G; Penicillin-Binding Proteins; Plasmids; Polysaccharides | 2007 |
Synergy between polyethylenimine and different families of antibiotics against a resistant clinical isolate of Pseudomonas aeruginosa.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbenicillin; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Novobiocin; Ofloxacin; Piperacillin; Polyethyleneimine; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Ticarcillin; Tobramycin | 2008 |
Discovery and characterization of QPT-1, the progenitor of a new class of bacterial topoisomerase inhibitors.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Bacteria; Bacterial Infections; Bacterial Proteins; Cell Line; Cell Proliferation; Metabolic Clearance Rate; Mice; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Stereoisomerism; Topoisomerase II Inhibitors | 2008 |
Functional cloning and characterization of the multidrug efflux pumps NorM from Neisseria gonorrhoeae and YdhE from Escherichia coli.
Topics: Anti-Bacterial Agents; Antiporters; ATP-Binding Cassette Transporters; Bacterial Proteins; Cloning, Molecular; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Ethidium; Fluorescence Polarization; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Norfloxacin | 2008 |
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids | 2008 |
RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.
Topics: Anti-Bacterial Agents; Antipsychotic Agents; Bacterial Proteins; Base Sequence; Chlorpromazine; DNA Primers; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Synergism; Ethidium; Gene Expression; Genes, Bacterial; Humans; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Mutation; Oligonucleotide Array Sequence Analysis; Phenothiazines; Salmonella typhimurium; Trans-Activators | 2008 |
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
Topics: Bacterial Proteins; beta-Lactamases; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cefepime; Cephalosporinase; Cephalosporins; Drug Resistance, Bacterial; Enterobacter aerogenes; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2009 |
Contribution of oxidative damage to antimicrobial lethality.
Topics: 2,2'-Dipyridyl; Anti-Bacterial Agents; Bacterial Proteins; Catalase; Escherichia coli; Escherichia coli Proteins; Hydroxyl Radical; Microbial Sensitivity Tests; Norfloxacin; Oxidative Stress; Superoxide Dismutase; Thiourea | 2009 |
Emergence of quinolone-resistant Bordetella pertussis in Japan.
Topics: Anti-Bacterial Agents; Bordetella pertussis; Child; DNA Gyrase; Fluoroquinolones; Humans; Japan; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Quinolones | 2009 |
Evaluation of target specificity of antibacterial agents using Staphylococcus aureus ddlA mutants and D-cycloserine in a silkworm infection model.
Topics: Animals; Anti-Bacterial Agents; Bombyx; Cephalosporins; Chloramphenicol; Cycloserine; Inhibitory Concentration 50; Larva; Microbial Sensitivity Tests; Staphylococcus aureus; Tetracycline; Vancomycin | 2009 |
CraA, a major facilitator superfamily efflux pump associated with chloramphenicol resistance in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Chloramphenicol Resistance; Drug Resistance, Multiple, Bacterial; Imipenem; Microbial Sensitivity Tests; Polymerase Chain Reaction; Quinolones; Tetracyclines | 2009 |
Role of porins in the susceptibility of Mycobacterium smegmatis and Mycobacterium chelonae to aldehyde-based disinfectants and drugs.
Topics: Antitubercular Agents; Disinfectants; Drug Resistance, Bacterial; Glutaral; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Mycobacterium chelonae; Mycobacterium smegmatis; o-Phthalaldehyde; Porins | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
High prevalence of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Bamako, Mali.
Topics: beta-Lactamases; Drug Resistance, Bacterial; Enterobacteriaceae; Humans; Random Amplified Polymorphic DNA Technique | 2009 |
Mutational upregulation of a resistance-nodulation-cell division-type multidrug efflux pump, SdeAB, upon exposure to a biocide, cetylpyridinium chloride, and antibiotic resistance in Serratia marcescens.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cetylpyridinium; Disinfectants; Drug Resistance, Multiple, Bacterial; Membrane Proteins; Mutation; Norfloxacin; Quaternary Ammonium Compounds; Serratia marcescens | 2009 |
Role of AbeS, a novel efflux pump of the SMR family of transporters, in resistance to antimicrobial agents in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Membrane Transport Proteins; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Homology, Amino Acid | 2009 |
Screening and quantification of the expression of antibiotic resistance genes in Acinetobacter baumannii with a microarray.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; DNA, Bacterial; DNA, Complementary; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Genes, MDR; Metals, Heavy; Microbial Sensitivity Tests; Mutation; Oligonucleotide Array Sequence Analysis; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; RNA, Bacterial | 2010 |
Constitutive SoxS expression in a fluoroquinolone-resistant strain with a truncated SoxR protein and identification of a new member of the marA-soxS-rob regulon, mdtG.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Oligonucleotide Array Sequence Analysis; Promoter Regions, Genetic; Regulon; Sequence Analysis, DNA; Trans-Activators; Transcription Factors | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents.
Topics: Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Carbapenems; Drug Resistance, Multiple, Bacterial; Erythromycin; Feces; Finland; Humans; Macrolides; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2010 |
Efflux pumps are involved in the defense of Gram-negative bacteria against the natural products isobavachalcone and diospyrone.
Topics: Bacterial Proteins; Carrier Proteins; Chalcones; Diospyros; Drug Discovery; Drug Resistance, Bacterial; Drug Resistance, Multiple; Enterobacter aerogenes; Enterobacter cloacae; Escherichia coli; Gram-Negative Bacteria; Klebsiella pneumoniae; Membrane Transport Proteins; Plant Proteins; Pseudomonas aeruginosa | 2010 |
Synthesis, antibacterial and antifungal activities of some carbazole derivatives.
Topics: Anti-Bacterial Agents; Antifungal Agents; Aspergillus fumigatus; Bacteria; Candida albicans; Carbazoles; Microbial Sensitivity Tests | 2010 |
Many chromosomal genes modulate MarA-mediated multidrug resistance in Escherichia coli.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Chromosomes, Bacterial; Colicins; Cyclic AMP Receptor Protein; DNA-Binding Proteins; Drug Resistance, Bacterial; Drug Resistance, Multiple; Escherichia coli; Escherichia coli Proteins; Fimbriae Proteins; Gene Expression Regulation, Bacterial; Lipoproteins; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Mutagenesis; Polynucleotide Adenylyltransferase | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
The BpeAB-OprB efflux pump of Burkholderia pseudomallei 1026b does not play a role in quorum sensing, virulence factor production, or extrusion of aminoglycosides but is a broad-spectrum drug efflux system.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Burkholderia pseudomallei; Culture Media; Drug Resistance, Multiple, Bacterial; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; Periplasmic Proteins; Quorum Sensing; Singapore; Virulence Factors | 2010 |
Synthesis and biological activities of novel amine-derived bis-azoles as potential antibacterial and antifungal agents.
Topics: Amines; Anti-Bacterial Agents; Antifungal Agents; Azoles; Bacteria; Fungi; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Structure-Activity Relationship | 2010 |
Optimized Nile Red efflux assay of AcrAB-TolC multidrug efflux system shows competition between substrates.
Topics: Anti-Bacterial Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chlortetracycline; Dipeptides; Doxorubicin; Doxycycline; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Minocycline; Onium Compounds; Organophosphorus Compounds; Tetracycline | 2010 |
Prevalence and dissemination of oqxAB in Escherichia coli isolates from animals, farmworkers, and the environment.
Topics: Animals; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Quinolones | 2010 |
Synthesis and antimicrobial activity of novel fluorine containing 4-(substituted-2-hydroxybenzoyl)-1H-pyrazoles and pyrazolyl benzo[d]oxazoles.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Bacillus subtilis; Bacteria; Bacterial Infections; Candida albicans; Candidiasis; Escherichia coli; Fluorine; Humans; Microbial Sensitivity Tests; Oxazoles; Pseudomonas aeruginosa; Pyrazoles; Staphylococcus aureus; Structure-Activity Relationship | 2010 |
Reduced expression of the vca0421 gene of Vibrio cholerae O1 results in innate resistance to ciprofloxacin.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Fluoroquinolones; Quinolones; Reverse Transcriptase Polymerase Chain Reaction; Vibrio cholerae O1 | 2010 |
Bernthsen synthesis, antimicrobial activities and cytotoxicity of acridine derivatives.
Topics: Acridines; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antineoplastic Agents; Aspergillus niger; Bacteria; Gram-Negative Bacteria; Gram-Positive Bacteria; Indicators and Reagents; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Spectrophotometry, Infrared | 2010 |
Importance of physicochemical properties for the design of new pesticides.
Topics: Anabasine; Animals; Biological Availability; Cell Membrane Permeability; Chemical Phenomena; Drug Design; Humans; Imidazoles; Insecticides; Neonicotinoids; Nitro Compounds; Pesticides; Quantitative Structure-Activity Relationship; Receptors, Nicotinic | 2011 |
Microwave assisted synthesis and antimicrobial evaluation of new fused pyran derivatives bearing 2-morpholinoquinoline nucleus.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Candida albicans; Fungi; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Microwaves; Mycoses; Pyrans; Quinolines | 2011 |
1,3-Dihydro-2H-indol-2-ones derivatives: design, synthesis, in vitro antibacterial, antifungal and antitubercular study.
Topics: Antifungal Agents; Antitubercular Agents; Chemistry Techniques, Synthetic; Drug Design; Fungi; Indoles; Microbial Sensitivity Tests; Mycobacterium tuberculosis | 2011 |
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics | 2012 |
An efficient one-pot synthesis, structure, antimicrobial and antioxidant investigations of some novel quinolyldibenzo[b,e][1,4]diazepinones.
Topics: Anti-Infective Agents; Antioxidants; Azepines; Crystallography, X-Ray; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Conformation; Quinolines | 2012 |
An improved microwave assisted one-pot synthesis, and biological investigations of some novel aryldiazenyl chromeno fused pyrrolidines.
Topics: Antifungal Agents; Antitubercular Agents; Aspergillus fumigatus; Azo Compounds; Benzopyrans; Candida albicans; Crystallography, X-Ray; Gram-Negative Bacteria; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Microwaves; Molecular Structure; Mycobacterium tuberculosis; Pyrrolidines; Stereoisomerism; Thiosemicarbazones | 2012 |
New N-arylamino biquinoline derivatives: synthesis, antimicrobial, antituberculosis, and antimalarial evaluation.
Topics: Antimalarials; Antitubercular Agents; Chemistry Techniques, Synthetic; Electrons; Fungi; Hydrophobic and Hydrophilic Interactions; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Plasmodium falciparum; Quinolines | 2012 |
Green synthesis and anti-infective activities of fluorinated pyrazoline derivatives.
Topics: Anti-Infective Agents; Antitubercular Agents; Bacteria; Bacterial Infections; Fungi; Green Chemistry Technology; Halogenation; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Mycoses; Pyrazoles; Tuberculosis | 2012 |
Synthesis and biological evaluation of novel benzimidazole derivatives and their binding behavior with bovine serum albumin.
Topics: Animals; Anti-Infective Agents; Bacteria; Benzimidazoles; Cattle; Chemistry Techniques, Synthetic; Fungi; Microbial Sensitivity Tests; Serum Albumin, Bovine; Thermodynamics | 2012 |
Novel berberine triazoles: synthesis, antimicrobial evaluation and competitive interactions with metal ions to human serum albumin.
Topics: Anti-Bacterial Agents; Antifungal Agents; Berberine; Binding, Competitive; Cations; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Metals; Microbial Sensitivity Tests; Serum Albumin; Triazoles | 2013 |
An efficient domino reaction in ionic liquid: synthesis and biological evaluation of some pyrano- and thiopyrano-fused heterocycles.
Topics: Aldehydes; Anti-Bacterial Agents; Coumarins; Gram-Negative Bacteria; Gram-Positive Bacteria; Heterocyclic Compounds; Ionic Liquids; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrans; Pyrazolones; Quinolines; Structure-Activity Relationship | 2013 |
Synthesis and identification of β-aryloxyquinoline based diversely fluorine substituted N-aryl quinolone derivatives as a new class of antimicrobial, antituberculosis and antioxidant agents.
Topics: Animals; Anti-Infective Agents; Antioxidants; Antitubercular Agents; Artemia; Aspergillus fumigatus; Candida albicans; Dose-Response Relationship, Drug; Fluorine; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Models, Chemical; Molecular Structure; Mycobacterium tuberculosis; Ovum; Quinolines; Structure-Activity Relationship | 2013 |
Synthesis and biological evaluation of a class of quinolone triazoles as potential antimicrobial agents and their interactions with calf thymus DNA.
Topics: Animals; Anti-Infective Agents; Bacteria; Cattle; DNA; DNA Replication; Drug Evaluation, Preclinical; Fungi; Intercalating Agents; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Quinolones; Spectrophotometry, Ultraviolet; Triazoles | 2013 |
Synthetic tactics of new class of 4-aminothieno[2,3-d]pyrimidine-6-carbonitrile derivatives acting as antimicrobial agents.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Benzoxazines; Dose-Response Relationship, Drug; Fungi; Microbial Sensitivity Tests; Molecular Structure; Piperidines; Structure-Activity Relationship | 2013 |
Design, synthesis and antimicrobial evaluation of novel benzimidazole type of Fluconazole analogues and their synergistic effects with Chloromycin, Norfloxacin and Fluconazole.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Benzimidazoles; Dose-Response Relationship, Drug; Drug Design; Drug Synergism; Fluconazole; Fungi; Microbial Sensitivity Tests; Norfloxacin; Structure-Activity Relationship | 2013 |
Design and synthesis of biquinolone-isoniazid hybrids as a new class of antitubercular and antimicrobial agents.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antitubercular Agents; Artemia; Bacteria; Dose-Response Relationship, Drug; Drug Design; Fungi; Isoniazid; Microbial Sensitivity Tests; Molecular Structure; Motor Activity; Quinolones; Structure-Activity Relationship; Tuberculosis | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Synthesis and biological evaluation of α-triazolyl chalcones as a new type of potential antimicrobial agents and their interaction with calf thymus DNA and human serum albumin.
Topics: Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Cattle; Chalcones; DNA; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Serum Albumin; Triazoles | 2014 |
1,2,3-Triazole-derived naphthalimides as a novel type of potential antimicrobial agents: synthesis, antimicrobial activity, interaction with calf thymus DNA and human serum albumin.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Cattle; DNA; DNA Replication; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Naphthalimides; Serum Albumin; Static Electricity; Structure-Activity Relationship; Triazoles | 2014 |
Synthesis, characterization and pharmacological screening of some novel 5-imidazopyrazole incorporated polyhydroquinoline derivatives.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Bacteria; Dose-Response Relationship, Drug; Fungi; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymers; Pyrazoles; Quinolines; Structure-Activity Relationship | 2014 |
Design, synthesis and characterization of fluoro substituted novel pyrazolylpyrazolines scaffold and their pharmacological screening.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Bacteria; Dose-Response Relationship, Drug; Drug Design; Fungi; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrazoles; Structure-Activity Relationship | 2014 |
Novel morpholinoquinoline nucleus clubbed with pyrazoline scaffolds: Synthesis, antibacterial, antitubercular and antimalarial activities.
Topics: Anti-Infective Agents; Antimalarials; Antitubercular Agents; Bacteria; Bacterial Infections; Fungi; Humans; Malaria, Falciparum; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Mycoses; Plasmodium falciparum; Pyrazoles; Quinolines; Structure-Activity Relationship; Tuberculosis | 2016 |
Novel 3-Aminothiazolquinolones: Design, Synthesis, Bioactive Evaluation, SARs, and Preliminary Antibacterial Mechanism.
Topics: Animals; Anti-Bacterial Agents; Cell Line; Cell Proliferation; Cell Survival; DNA Gyrase; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; PC12 Cells; Quinolones; Rats; Structure-Activity Relationship; Thiazoles | 2016 |
Design, synthesis and biological evaluation of berberine-benzimidazole hybrids as new type of potentially DNA-targeting antimicrobial agents.
Topics: Animals; Anti-Infective Agents; Bacteria; Benzimidazoles; Berberine; Cattle; Cell Membrane Permeability; Chemistry Techniques, Synthetic; DNA; Drug Design; Fungi; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Protein Conformation; Serum Albumin; Water | 2016 |
Multi-targeting exploration of new 2-aminothiazolyl quinolones: Synthesis, antimicrobial evaluation, interaction with DNA, combination with topoisomerase IV and penetrability into cells.
Topics: Animals; Anti-Infective Agents; Biological Transport; Cattle; Cell Line; Cell Membrane Permeability; Chemistry Techniques, Synthetic; DNA; DNA Replication; DNA Topoisomerase IV; Drug Design; Kinetics; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Permeability; Quinolones | 2016 |
Synthesis and biological screening of novel 2-morpholinoquinoline nucleus clubbed with 1,2,4-oxadiazole motifs.
Topics: Anti-Infective Agents; Bacteria; Bacterial Proteins; Catalytic Domain; Chemistry Techniques, Synthetic; Drug Evaluation, Preclinical; Fungi; Microbial Sensitivity Tests; Molecular Docking Simulation; Oxadiazoles; Quinolines; Structure-Activity Relationship | 2017 |
Novel benzimidazolyl tetrahydroprotoberberines: Design, synthesis, antimicrobial evaluation and multi-targeting exploration.
Topics: Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Benzimidazoles; Berberine Alkaloids; Cattle; DNA; Fungi; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycoses | 2017 |
Design, synthesis and antimicrobial evaluation of novel benzimidazole-incorporated sulfonamide analogues.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Benzimidazoles; Cattle; DNA; Dose-Response Relationship, Drug; Drug Design; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure; Serum Albumin; Structure-Activity Relationship; Sulfonamides | 2017 |
1,2,4-Triazole and 1,3,4-oxadiazole analogues: Synthesis, MO studies, in silico molecular docking studies, antimalarial as DHFR inhibitor and antimicrobial activities.
Topics: Anti-Infective Agents; Antimalarials; Folic Acid Antagonists; Molecular Docking Simulation; Oxadiazoles; Spectrum Analysis; Triazoles | 2017 |
Benzothiazole analogues: Synthesis, characterization, MO calculations with PM6 and DFT, in silico studies and in vitro antimalarial as DHFR inhibitors and antimicrobial activities.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Benzothiazoles; Cell Survival; Computer Simulation; Dose-Response Relationship, Drug; Folic Acid Antagonists; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Structure; Plasmodium falciparum; Quantum Theory; Schizosaccharomyces; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase | 2017 |
Azoalkyl ether imidazo[2,1-b]benzothiazoles as potentially antimicrobial agents with novel structural skeleton.
Topics: Anti-Bacterial Agents; Antifungal Agents; Benzothiazoles; Dose-Response Relationship, Drug; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Structure; Quantum Theory; Structure-Activity Relationship | 2018 |
Design, synthesis, and biological activity of novel ammonium salts containing sterically hindered phenolic fragment and phosphoryl group.
Topics: | 2018 |
Structure based design, synthesis, and biological evaluation of imidazole derivatives targeting dihydropteroate synthase enzyme.
Topics: Anti-Bacterial Agents; Dihydropteroate Synthase; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Imidazoles; Ligands; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Structure-Activity Relationship; Vancomycin-Resistant Enterococci | 2021 |
Comparative in vitro activity of enoxacin and other fluoroquinolones against multi-resistant strains of Salmonella typhi.
Topics: Ampicillin; Anti-Infective Agents; Chloramphenicol; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Quinolones; Salmonella typhi; Species Specificity; Trimethoprim, Sulfamethoxazole Drug Combination; Typhoid Fever | 1992 |
Fluoroquinolone supersusceptibility mediated by outer membrane protein OprH overexpression in Pseudomonas aeruginosa: evidence for involvement of a nonporin pathway.
Topics: Anti-Infective Agents; Bacterial Outer Membrane Proteins; Cell Membrane; Chloramphenicol; Ciprofloxacin; Drug Resistance, Microbial; Fleroxacin; Gene Expression; Norfloxacin; Porins; Pseudomonas aeruginosa | 1992 |
Occurrence of the nfxB type mutation in clinical isolates of Pseudomonas aeruginosa.
Topics: Carbenicillin; Chloramphenicol; Drug Resistance, Microbial; Genes, Bacterial; Gentamicins; Imipenem; Microbial Sensitivity Tests; Mutation; Norfloxacin; Phenotype; Plasmids; Pseudomonas aeruginosa; Transformation, Bacterial | 1992 |
The problem of emerging chloramphenicol resistance in typhoid fever--a preliminary report.
Topics: Chloramphenicol; Chloramphenicol Resistance; Disease Outbreaks; Humans; India; Microbial Sensitivity Tests; Norfloxacin; Salmonella typhi; Typhoid Fever | 1991 |
Norfloxacin ophthalmic versus chloramphenicol in bacterial conjunctivitis and blepharoconjunctivitis.
Topics: Chloramphenicol; Conjunctivitis, Bacterial; Humans; Norfloxacin | 1990 |
Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction.
Topics: Anti-Infective Agents; Bacterial Outer Membrane Proteins; Bacteriophages; Chloramphenicol; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Polyacrylamide Gel; Escherichia coli; Microbial Sensitivity Tests; Mutation; Norfloxacin; Tetracycline | 1989 |
Evaluation of the in vitro bactericidal action of ciprofloxacin on cells of Escherichia coli in the logarithmic and stationary phases of growth.
Topics: Chloramphenicol; Ciprofloxacin; Drug Interactions; Escherichia coli; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Norfloxacin; Quinolines; Time Factors | 1985 |
[Comparative efficacy of ampicillin, chloramphenicol, cefotaxime, ceftriaxone and pefloxacin in experimental Salmonella typhimurium infection].
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Chloramphenicol; Female; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Norfloxacin; Pefloxacin; Salmonella Infections, Animal; Salmonella typhimurium | 1987 |
Evaluation of pefloxacin in experimental Escherichia coli meningitis.
Topics: Animals; Anti-Infective Agents; Cefotaxime; Chloramphenicol; Escherichia coli Infections; Humans; Meningitis; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Rabbits; Time Factors | 1986 |
Antimicrobial activity of norfloxacin in enteric and urinary tract infections: combined effect of norfloxacin with aminoglycosides, tetracycline and chloramphenicol.
Topics: Acinetobacter; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Chloramphenicol; Drug Combinations; Enterobacteriaceae; Gastrointestinal Diseases; Humans; Microbial Sensitivity Tests; Norfloxacin; Pipemidic Acid; Pseudomonas; Tetracycline; Urinary Tract Infections | 1986 |
In vitro susceptibility of pathogenic Vibrio species to norfloxacin and six other antimicrobial agents.
Topics: Ampicillin; Chloramphenicol; Gentamicins; In Vitro Techniques; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Sulfamethoxazole; Tetracycline; Trimethoprim; Vibrio | 1985 |
Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: resistance to tetracycline, chloramphenicol, and norfloxacin.
Topics: Chloramphenicol; Chloramphenicol Resistance; Drug Resistance, Microbial; Membrane Proteins; Mutation; Norfloxacin; Pseudomonas aeruginosa; Tetracycline; Tetracycline Resistance | 1994 |
The accumulation of five antibacterial agents in porin-deficient mutants of Escherichia coli.
Topics: Anti-Infective Agents; Cefoxitin; Cephalosporins; Chloramphenicol; Escherichia coli; Microbial Sensitivity Tests; Mutation; Norfloxacin; Phenotype; Porins; Tetracycline | 1993 |
Role of mexA-mexB-oprM in antibiotic efflux in Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Outer Membrane Proteins; Chloramphenicol; DNA Transposable Elements; Microbial Sensitivity Tests; Norfloxacin; Operon; Penicillin G; Penicillins; Pseudomonas aeruginosa; Tetracycline | 1995 |
Overexpression of the mexC-mexD-oprJ efflux operon in nfxB-type multidrug-resistant strains of Pseudomonas aeruginosa.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chloramphenicol; Cloning, Molecular; DNA-Binding Proteins; Drug Resistance, Microbial; Drug Resistance, Multiple; Gene Expression Regulation, Bacterial; Genes, Bacterial; Ionophores; Molecular Sequence Data; Norfloxacin; Operon; Point Mutation; Pseudomonas aeruginosa; Transcription Factors | 1996 |
Dependence of peptidoglycan metabolism on phospholipid synthesis during growth of Escherichia coli.
Topics: Ampicillin; Ampicillin Resistance; Cerulenin; Chloramphenicol; Enzyme Inhibitors; Escherichia coli; Glycerol; Guanosine Tetraphosphate; Norfloxacin; Penicillins; Peptidoglycan; Phospholipids; Protein Synthesis Inhibitors; Topoisomerase II Inhibitors | 1996 |
Active efflux of antimicrobial agents in wild-type strains of enterococci.
Topics: Anti-Bacterial Agents; Chloramphenicol; Enterococcus faecalis; Enterococcus faecium; Microbial Sensitivity Tests; Norfloxacin; Tetracycline | 1997 |
[The drug susceptibility pattern of the presumed etiologic agents of infectious enteritis including verotoxin-producing Escherichia coli O-157].
Topics: Aerobiosis; Ampicillin; Anaerobiosis; Anti-Bacterial Agents; Anti-Infective Agents; Campylobacter jejuni; Cefaclor; Cephalosporins; Chloramphenicol; Drug Resistance, Microbial; Enteritis; Escherichia coli O157; Fosfomycin; Humans; Microbial Sensitivity Tests; Minocycline; Norfloxacin; Penicillins; Salmonella; Tetracycline; Vibrio parahaemolyticus | 1997 |
Antimicrobial resistance of Enterococci in Lebanon.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Chloramphenicol; Ciprofloxacin; Drug Resistance, Microbial; Enterococcus; Erythromycin; Gentamicins; Humans; Lebanon; Microbial Sensitivity Tests; Norfloxacin; Penicillins; Rifampin; Streptomycin; Teicoplanin; Tetracycline; Vancomycin | 2001 |
Antibiotic susceptibility pattern of Salmonella worthington isolated from neonates--a retrospective study.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Chloramphenicol; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Humans; Infant, Newborn; Infant, Newborn, Diseases; Meningitis; Norfloxacin; Penicillins; Prevalence; Retrospective Studies; Salmonella; Salmonella Infections; Sepsis; Time Factors | 2002 |
Microsporidial keratoconjunctivitis in healthy individuals: a case series.
Topics: Adolescent; Adult; Albendazole; Antiprotozoal Agents; Chloramphenicol; Cornea; Cyclohexanes; Drug Therapy, Combination; Eye Infections, Parasitic; Fatty Acids, Unsaturated; HIV Seronegativity; Humans; Keratoconjunctivitis; Male; Microsporidiosis; Norfloxacin; Retrospective Studies; Sesquiterpenes | 2003 |
[Activity of fosfomycin against Escherichia coli O157:H7--morphological changes and production of Shiga toxins].
Topics: Ampicillin; Anti-Bacterial Agents; Bacteriolysis; Cell Wall; Chloramphenicol; Dose-Response Relationship, Drug; Escherichia coli O157; Fosfomycin; Kanamycin; Norfloxacin; Shiga Toxins | 2003 |
Antibiotic sensitivity patterns among Indian strains of avian Pasteurella multocida.
Topics: Animals; Anti-Bacterial Agents; Chloramphenicol; Doxycycline; Enrofloxacin; Fluoroquinolones; India; Lincomycin; Microbial Sensitivity Tests; Norfloxacin; Pasteurella Infections; Pasteurella multocida; Poultry; Poultry Diseases; Quinolones; Species Specificity; Sulfadiazine | 2004 |
The use of quinolones in the treatment of acute bacterial diarrhea: a comparative therapeutic trial.
Topics: Acute Disease; Adolescent; Anti-Infective Agents; Bacteria; Bacterial Infections; Chloramphenicol; Diarrhea; Feces; Female; Humans; Male; Norfloxacin; Quinolones; Randomized Controlled Trials as Topic; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination | 1989 |
Determination of selected antibiotics in the Victoria Harbour and the Pearl River, South China using high-performance liquid chromatography-electrospray ionization tandem mass spectrometry.
Topics: Amoxicillin; Anti-Bacterial Agents; China; Chloramphenicol; Chromatography, High Pressure Liquid; Climate; Erythromycin; Hong Kong; Macrolides; Norfloxacin; Ofloxacin; Quinolones; Rivers; Seasons; Seawater; Spectrometry, Mass, Electrospray Ionization; Sulfanilamides; Time Factors; Waste Management; Water Pollutants, Chemical | 2007 |
An alkylaminoquinazoline restores antibiotic activity in Gram-negative resistant isolates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Chloramphenicol; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Membrane Transport Proteins; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Quinazolines | 2011 |
Treatment of microsporidial keratoconjunctivitis with repeated corneal swabbing.
Topics: Adult; Aged; Anti-Bacterial Agents; Chloramphenicol; Cornea; DNA, Bacterial; Drug Therapy, Combination; Eye Infections, Fungal; Female; Humans; Keratoconjunctivitis; Male; Microsporidia; Microsporidiosis; Middle Aged; Norfloxacin; Polymerase Chain Reaction; Retrospective Studies; RNA, Bacterial; RNA, Ribosomal, 16S; Surgical Sponges; Young Adult | 2012 |
Phytotoxicity of veterinary antibiotics to seed germination and root elongation of crops.
Topics: Animals; Anti-Bacterial Agents; Chloramphenicol; Crops, Agricultural; Cucumis sativus; Daucus carota; Erythromycin; Germination; Lactuca; Norfloxacin; Plant Roots; Quantitative Structure-Activity Relationship; Seeds; Soil Pollutants; Solanum lycopersicum; Sulfamethazine; Tetracycline; Veterinary Drugs | 2016 |
Assessment of altered binding specificity of bacteriophage for ciprofloxacin-induced antibiotic-resistant Salmonella Typhimurium.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; Bacteriophages; beta-Lactamases; Binding Sites; Chloramphenicol; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Membrane Transport Proteins; Microbial Sensitivity Tests; Norfloxacin; Salmonella typhimurium; Tetracycline; Trans-Activators | 2016 |
Combined treatment of UVA irradiation and antibiotics induces greater bactericidal effects on Vibrio parahaemolyticus.
Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Disinfection; Gentamicins; Humans; Norfloxacin; Ultraviolet Rays; Vibrio parahaemolyticus | 2016 |
Designation of pathogenic resistant bacteria in the Sparusaurata sea collected in Tunisia coastlines: Correlation with high performance liquid chromatography-tandem mass spectrometry analysis of antibiotics.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Aquaculture; Bacteria; Chloramphenicol; Chromatography, High Pressure Liquid; Colistin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Fish Diseases; Fisheries; Food Contamination; Fusidic Acid; Microbial Sensitivity Tests; Norfloxacin; Sea Bream; Seafood; Seawater; Tandem Mass Spectrometry; Tunisia; Vibrio alginolyticus; Vibrio Infections; Vibrio parahaemolyticus; Water Pollutants, Chemical | 2017 |
Occurrence, virulence genes, and antimicrobial profiles of Escherichia coli O157 isolated from ruminants slaughtered in Al Ain, United Arab Emirates.
Topics: Animals; Anti-Bacterial Agents; Camelus; Cattle; Cefotaxime; Chloramphenicol; Ciprofloxacin; Escherichia coli Infections; Escherichia coli Proteins; Feces; Female; Food Microbiology; Goats; Male; Microbial Sensitivity Tests; Norfloxacin; Polymyxin B; Prevalence; Ruminants; Sheep; Shiga-Toxigenic Escherichia coli; United Arab Emirates; Virulence Factors | 2020 |
Isolation, identification, and antimicrobial susceptibility pattern of Campylobacter jejuni and Campylobacter coli from cattle, goat, and chicken meats in Mekelle, Ethiopia.
Topics: Amoxicillin; Ampicillin; Animals; Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Cattle; Chickens; Chloramphenicol; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Erythromycin; Ethiopia; Goats; Meat; Microbial Sensitivity Tests; Norfloxacin; Prevalence; Streptomycin; Sulfamethoxazole; Trimethoprim | 2021 |
Simultaneous removal of norfloxacin and chloramphenicol using cold atmospheric plasma jet (CAPJ): Enhanced performance, synergistic effect, plasma-activated water (PAW) contribution, mechanism and toxicity evaluation.
Topics: Anti-Bacterial Agents; Chloramphenicol; Humans; Norfloxacin; Plasma Gases; Reactive Nitrogen Species; Reactive Oxygen Species; Water | 2023 |